Corporate Update: Porton Pharma L and Peer Performance
On Monday, 26 May 2026, the shares of Porton Pharma L (ticker 300363.SZ) exhibited a muted performance, trading flat at 0 % during the 24‑hour period ending at 08:58 AM Central Europe. The current price on major exchanges sits at approximately CNY 21.01. With a market capitalisation of CNY 11.3 billion and a circulating supply of 536.4 million shares, the company’s trading volume over the past 24 hours amounted to CNY 344.6 million.
Historical Context and Technical Indicators
- Price Range (52 Weeks): The highest price reached CNY 30.4 on 14 January 2026, while the low was CNY 13.24 on 8 June 2026.
- Moving Average: The simple moving average over the last 200 days stands at CNY 18.81.
- Recent Trend: Since the end of last month, Porton Pharma L has seen a decline of 11.29 %.
Peer Activity
| Company | Ticker | 24‑Hour Movement | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|---|
| Beijing Tricolor Technology | 603516.SS | 0 % | CNY 63.78 | CNY 13.6 bn | 29.12 |
| Chongqing Rural Commercial‑H | 3618.HK | -1.17 % | HKD 6.42 | HKD 15.9 bn | 4.99 |
| Lao Feng Xiang | 600612.SS | 0 % | CNY 32.6 | CNY 13.5 bn | 13.39 |
| Apichope Pharmaceutical Group | 300723.SZ | 0 % | CNY 30.2 | CNY 13.6 bn | 62.02 |
| Mehow Innovative | 301363.SZ | 0 % | CNY 16.53 | CNY 13.5 bn | – |
Lao Feng Xiang, for instance, has not released any new financial reports or corporate announcements within the last week, and no significant corporate actions—including mergers, acquisitions, or share‑repurchase plans—have been disclosed. Consequently, analysts and investors are currently operating without fresh data to revise near‑term expectations.
Company Profile
Porton Pharma Solutions Ltd., headquartered in Chongqing, specializes in the manufacture and supply of drug intermediates and active pharmaceutical ingredients. Since its founding in 2005, the company has expanded its portfolio to include chirally pure drug intermediates, unnatural amino acids, heterocyclic compounds, aromatic and hetero‑aromatic derivatives, and azides. Originally known as Porton Fine Chemicals Ltd., the firm rebranded to Porton Pharma Solutions Ltd. in January 2018. It trades on the Shenzhen Stock Exchange and maintains an online presence at www.porton.cn .
The information presented here reflects the market conditions and corporate disclosures available as of the stated reporting period. Investors should conduct further due diligence before making investment decisions.
